Use of PAM

Details for Australian Patent Application No. 2004243538 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Michaelis, Martin; Tegeder, Irmgard; Scholich, Klaus; Geisslinger, Gerd

Agent Watermark

Pub. Number AU-B-2004243538

PCT Pub. Number WO2004/105785

Priority 03012388.9 30.05.03 EP

Filing date 29 April 2004

Wipo publication date 9 December 2004

Acceptance publication date 22 October 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105785 Priority application(s): WO2004/105785

22 October 2009 Application Accepted

  Published as AU-B-2004243538

10 December 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Nov 2009. Address for service in Australia - Watermark Patent & Trademark Attorneys Level 2, 302 Burwood Road Hawthorn VIC 3122

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243541-Compositions comprising gastrin compounds and their use in diabetes

2004243537-Satiety enhancing food products